FundedIQ
Biotechnology

Pixelgen Technologies: Funding, Investors & Team (Sep 2026)

Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and diagnostics through the development of innovative technologies.

www.pixelgen.com LinkedIn Stockholm, Sweden 11-50 employees Founded 2020
Total raised
$22.8M
Rounds
2
Latest
Series B
Aug 2026

Pixelgen Technologies has raised $22.8M across 2 funding rounds on record, the most recent a Series B of $15.5M announced in Aug 2026.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Pixelgen Technologies Company Profile and Key Stats

Total funding raised
$22.8M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series B
$15.5M in Aug 2026
Employees
11-50
reported band
Founded
2020
Headquarters
Stockholm, Sweden
Investors on record
6
5 named below

Latest funding round on record: Aug 2026.

Pixelgen Technologies Funding Rounds

Date
Round
Amount
Series B
$15.5M
Series A
$7.3M

Pixelgen Technologies raised $7.3M in a Series A announced in Oct 2023.

2.8 years later, a Series B of $15.5M was announced in Aug 2026.

Pixelgen Technologies Investors

Flat Capital EIC Accelerator Industrifonden Navigare Ventures Colibri Ventures

6 investors are recorded in total; the 5 named above are those the record identifies.

Pixelgen Technologies Founders and Leadership Team

Name
Role
Contact
Simon Fredriksson
CEO
Locked
Filip Karlsson
CTO
Locked

Contact details for the Pixelgen Technologies team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.

Start 14-day free trial →

Pixelgen Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
688
$4.2M
4,289
$30M

Pixelgen Technologies' latest round of $15.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Pixelgen Technologies in Biotechnology and Stockholm

Companies Similar to Pixelgen Technologies

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…

Undisclosed round $1.4M

Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.

Pre-Seed $740k

Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…

Undisclosed round $790k

OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…

Undisclosed round $1.6M

Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…

Undisclosed round $150k

Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…

Undisclosed round $2.1M

Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…

Undisclosed round $20.0M

Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…

Undisclosed round $60k

Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…

Undisclosed round $11.9M

Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…

Undisclosed round $9.3M

ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…

Undisclosed round $7.4M

Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D…

Seed $4.6M

Pixelgen Technologies Funding FAQs

What does Pixelgen Technologies do?

Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and diagnostics through the development of innovative technologies.

How much funding has Pixelgen Technologies raised?

Pixelgen Technologies has raised $22.8M across 2 rounds on record. The most recent is a Series B of $15.5M announced in Aug 2026.

When did Pixelgen Technologies last raise funding?

Pixelgen Technologies' most recent funding round on record is a Series B of $15.5M, announced in Aug 2026.

Who has invested in Pixelgen Technologies?

Investors on record for Pixelgen Technologies include Flat Capital, EIC Accelerator, Industrifonden, Navigare Ventures, Colibri Ventures. FundedIQ records 6 investors in total.

Who is the CEO of Pixelgen Technologies?

Simon Fredriksson is listed as CEO at Pixelgen Technologies.

Where is Pixelgen Technologies headquartered?

Pixelgen Technologies is based in Stockholm, Stockholms Lan, Sweden.

How many employees does Pixelgen Technologies have?

Pixelgen Technologies is in the 11-50 employee band.

When was Pixelgen Technologies founded?

Pixelgen Technologies was founded in 2020.

How does Pixelgen Technologies' funding compare to other Biotechnology startups?

Pixelgen Technologies' latest round of $15.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Pixelgen Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pixelgen Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.